- Service Name
GenoScaler™
- Industry
Life Sciences, Biotechnology, Genetic Engineering, Biomanufacturing
- Main Value Proposition
The primary value offered is the ability to make biomanufacturing scalable, cost-effective, and safe through advanced genetic engineering technologies.
- Description
GenoScaler™ is a technology platform that leverages Directed Evolution, CRISPR+, and Machine Learning to enhance biomanufacturing processes. It enables the rapid identification and recombination of genetic edits to create strains with high commercial potential, making biomanufacturing more efficient and cost-effective.
- Key Features
Lean Bioengineering™ approach for increased success and lower costs; GenoScaler™ technology for rapid strain improvement; Machine learning models for efficient data analysis; Cost-effective biomanufacturing at $0.10/variant
- Use Cases
Primary scenarios where the service is most valuable include biomanufacturing of sustainable products, genetic research and development, and improving the efficiency of strain engineering processes.
- Competitive advantages
4x faster strain engineering cycles compared to state-of-the-art methods; 1,000x more cost-effective at $0.10 per variant; Requires only 0.5−3 full-time equivalents per project, making it more efficient
- Strengths
The main strengths include its innovative approach to bioengineering, significant cost savings, rapid turnaround times, and the ability to handle large sets of genetic solutions efficiently.
- Positioning
GenoScaler™ positions itself as a cutting-edge solution in the biomanufacturing industry, emphasizing speed, cost-effectiveness, and innovation.
- Audience
The target users include biotechnology companies, research institutions, and organizations focused on sustainable manufacturing solutions.
- CTA
Learn more
- Tags
biomanufacturing
genome engineering
sustainable products
biotechnology
- Tagline
Harnessing the power of biology and data science to bring affordable and sustainable biomanufactured products to market.
- Tone of Voice
Innovative, authoritative, efficient
- Differentiation
GenoScaler™ differentiates itself by combining multiple advanced technologies (Directed Evolution, CRISPR+, and Machine Learning) to significantly speed up the strain engineering process and reduce costs compared to traditional methods.
- Brand Positioning
Inscripta® is positioned as a leader in digital genome engineering, committed to advancing the bioeconomy through innovative technologies.
- Founded
2015-01-01
- Founders
Andrew Garst
Ryan T. Gill
Tanya Warnecke